David Collett1, Peter J Friend, Christopher J E Watson. 1. 1 Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, United Kingdom. 2 Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom. 3 University of Cambridge Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom. 4 The National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation at the University of Cambridge, Cambridge, United Kingdom.
Abstract
BACKGROUND: A measure of donor liver quality, the donor liver index, was developed and validated for the UK population of transplant recipients. Unlike previously proposed measures, this index is only based on variables that are available at the point of retrieval, and so does not include cold ischemic time. METHODS: Indices of liver quality were based on data from the UK Transplant Registry on all 7929 liver transplants between January 2000 and December 2014. RESULTS: The donor liver index (DLI) was based on factors shown to affect graft survival, which included donor age, sex, height, type (donor after brain death or circulatory death), bilirubin, smoking history, and whether the liver was split. A separate index (DLI1) looking at 1-year survival showed donor cardiac disease, black ethnicity, and steatosis to be additional risk factors. A strong association was found between DLI and whether or not a surgeon accepts an offered liver for transplant, with a marked fall in acceptance rates for livers with an index greater than 1.31. Since 2000, there has been a notable reduction in the quality of livers transplanted, coupled with variation between the 7 UK liver transplant centers in risk appetite. CONCLUSIONS: The DLI is an index of liver quality which enables analysis of the changing trends in liver quality and center behavior. DLI1 enables identification of factors affecting shorter-term survival, and perhaps identifies a cohort of livers that may benefit from novel preservation technologies.
BACKGROUND: A measure of donor liver quality, the donor liver index, was developed and validated for the UK population of transplant recipients. Unlike previously proposed measures, this index is only based on variables that are available at the point of retrieval, and so does not include cold ischemic time. METHODS: Indices of liver quality were based on data from the UK Transplant Registry on all 7929 liver transplants between January 2000 and December 2014. RESULTS: The donor liver index (DLI) was based on factors shown to affect graft survival, which included donor age, sex, height, type (donor after brain death or circulatory death), bilirubin, smoking history, and whether the liver was split. A separate index (DLI1) looking at 1-year survival showed donorcardiac disease, black ethnicity, and steatosis to be additional risk factors. A strong association was found between DLI and whether or not a surgeon accepts an offered liver for transplant, with a marked fall in acceptance rates for livers with an index greater than 1.31. Since 2000, there has been a notable reduction in the quality of livers transplanted, coupled with variation between the 7 UK liver transplant centers in risk appetite. CONCLUSIONS: The DLI is an index of liver quality which enables analysis of the changing trends in liver quality and center behavior. DLI1 enables identification of factors affecting shorter-term survival, and perhaps identifies a cohort of livers that may benefit from novel preservation technologies.
Authors: W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2016-01 Impact factor: 8.086
Authors: Eric S Weiss; Jeremiah G Allen; Arman Kilic; Stuart D Russell; William A Baumgartner; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2011-11-16 Impact factor: 10.247
Authors: S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion Journal: Am J Transplant Date: 2006-04 Impact factor: 8.086
Authors: Glenn K Bonney; Mark A Aldersley; Sonal Asthana; Giles J Toogood; Stephen G Pollard; J Peter A Lodge; K Rajendra Prasad Journal: Transplantation Date: 2009-06-27 Impact factor: 4.939
Authors: Karen J Ho; Christopher D Owens; Scott R Johnson; Khalid Khwaja; Michael P Curry; Martha Pavlakis; Didier Mandelbrot; James J Pomposelli; Shimul A Shah; Reza F Saidi; Dicken S C Ko; Sayeed Malek; John Belcher; David Hull; Stefan G Tullius; Richard B Freeman; Elizabeth A Pomfret; James F Whiting; Douglas W Hanto; Seth J Karp Journal: Transplantation Date: 2008-06-15 Impact factor: 4.939
Authors: Irene Beijert; Safak Mert; Viola Huang; Negin Karimian; Sharon Geerts; Ehab O A Hafiz; James F Markmann; Heidi Yeh; Robert J Porte; Korkut Uygun Journal: Transplant Direct Date: 2018-04-23
Authors: Uwe Scheuermann; Elisabeth R Seyferth; Nader Abraham; Samuel J Kesseli; Samantha E Halpern; Minghua Zhu; Mingqing Song; Matthew G Hartwig; William Parker; Jean Kwun; Anne D Cherry; Jaewoo Lee; Andrew S Barbas Journal: Sci Rep Date: 2020-07-17 Impact factor: 4.379
Authors: Christopher J E Watson; Vasilis Kosmoliaptsis; Lucy V Randle; Alexander E Gimson; Rebecca Brais; John R Klinck; Mazin Hamed; Anastasia Tsyben; Andrew J Butler Journal: Transplantation Date: 2017-05 Impact factor: 4.939
Authors: Christopher J E Watson; Vasilis Kosmoliaptsis; Caitlin Pley; Lucy Randle; Corinna Fear; Keziah Crick; Alexander E Gimson; Michael Allison; Sara Upponi; Rebecca Brais; Ina Jochmans; Andrew J Butler Journal: Am J Transplant Date: 2018-03-14 Impact factor: 8.086
Authors: Uwe Scheuermann; Tracy Truong; Elisabeth R Seyferth; Kyle Freischlag; Qimeng Gao; John Yerxa; Brian Ezekian; Robert P Davis; Paul M Schroder; Sarah B Peskoe; Andrew S Barbas Journal: Transplant Direct Date: 2019-11-25